Krishnavathana Varatharajalu

机构：The University of Texas MD Anderson Cancer Center

发表论文 72 篇 · 总被引 153 次 · h-index 7

代表论文

• Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events (2024 · Journal for ImmunoTherapy of Cancer · 被引 42)
• Gastrointestinal toxicities associated with immune checkpoint inhibitors therapy: risks and management (2025 · Immunotherapy · 被引 7)
• S310 Fecal Transplantation Improved Patients’ Reported Outcome After Immune Checkpoint Inhibitor Colitis (2024 · The American Journal of Gastroenterology · 被引 5)
• Gastrointestinal toxicities of proteasome inhibitor therapy (2024 · Journal of Cancer Research and Clinical Oncology · 被引 5)
• First-line treatment of fecal microbiota transplantation for immune-mediated colitis. (2024 · Journal of Clinical Oncology · 被引 4)
• Validation of the immune-mediated colitis endoscopic score using a retrospective cohort of patients with immune-mediated colitis (2025 · iGIE · 被引 2)